Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...
Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
New research from researchers at the University of Florida, University of Maryland and Yale School of Public Health has found that if measles, mumps and rubella (MMR) immunization rates continue to ...
April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offerings ...
In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...
CHENGDU, China, April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that results from both the ovarian cancer cohort ...
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will ...
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and ...
Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The ...
CAR-T therapies are continuing to gain traction in autoimmune disease, with a notable new case. Also, the FDA has withdrawn ...
ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies, an industry leader in investor relations, media, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results